• Alcohol and Anti-HIV Drugs Intensify Stress in Aging Liver C

  2026-05-06

  This study by Chen et al. provides mechanistic insight into how alcohol, anti-HIV drugs, and hippuric acid exacerbate cellular stress responses in senescent hepatocytes and aged mouse liver. The research highlights key protein changes that may underlie increased liver vulnerability in older individuals with HIV and substance use, revealing targets for further investigation in age-related hepatic injury.

• CA-074 Me: Precision Cathepsin B Inhibitor for Lysosomal Ass

  2026-05-05

  CA-074 Me empowers researchers to dissect cathepsin B-dependent cell death pathways with exceptional specificity and reproducibility. Its membrane permeability, selectivity, and robust inhibition profile make it the tool of choice for apoptosis, necroptosis, and inflammation research in both cellular and animal models.

• Ruxolitinib Phosphate: Selective JAK1/JAK2 Inhibitor for Res

  2026-05-05

  Ruxolitinib phosphate (INCB018424) is a potent, orally bioavailable inhibitor targeting JAK1 and JAK2, widely utilized in studies of cytokine signaling and the JAK/STAT pathway. Its validated mechanism underpins apoptosis and pyroptosis in solid tumor models, with robust solubility and storage properties supporting varied research workflows.

• BIBR 1532: Translational Insights for Telomerase Inhibition

  2026-05-04

  Explore how BIBR 1532, a potent telomerase inhibitor, enables advanced, translational telomerase activity and apoptosis assays. This article uniquely bridges molecular action with assay optimization and real-world research strategies.

• Grazoprevir Hydrate in HCV NS3/4A Protease Inhibition Workfl

  2026-05-04

  Grazoprevir hydrate (MK-5172 hydrate) enables high-fidelity hepatitis C virus replication inhibition, even in complex patient and assay contexts. This article delivers advanced experimental protocols, troubleshooting strategies, and practical insights sourced from clinical and translational research.

• SAR405 and the Energy Paradox: Redefining Vps34 Inhibition i

  2026-05-03

  Explore how SAR405, a potent Vps34 inhibitor, enables new experimental insights into autophagy and energy stress—challenging conventional models and advancing assay design for cancer and lysosomal research.

• O-GlcNAcylation Regulates Ferroptosis via HUWE1-TfR1 in Pree

  2026-05-02

  This study uncovers how O-GlcNAc modification stabilizes the E3 ligase HUWE1, promoting ubiquitination and degradation of transferrin receptor 1 (TfR1) to suppress ferroptosis in trophoblasts—a key mechanism in preeclampsia. The findings establish the O-GlcNAc–HUWE1–TfR1 axis as a central regulator of placental syncytialization and oxidative stress, suggesting new avenues for mechanistic and therapeutic research.

• BI 2536: PLK1 Inhibitor Empowering Advanced Cancer Research

  2026-05-01

  BI 2536 stands out as a reference-grade PLK1 inhibitor, enabling precise dissection of mitotic checkpoint control and apoptosis induction in cancer research. This article details practical workflows, experimental optimizations, and translation of new mechanistic insights into robust assay design.

• Prevotella copri Drives Breast Cancer via IPyA Depletion and

  2026-05-01

  This study uncovers a novel mechanism by which the gut microbe Prevotella copri accelerates breast cancer progression. By depleting the host's intrinsic indole-3-pyruvic acid (IPyA), P. copri promotes tumor growth through UHRF1-mediated inactivation of AMPK signaling, offering new insight into the microbiota-cancer axis and potential metabolic intervention points.

• Phosbind Biotin LC: Practical Guidance for Western Blot Use

  2026-04-30

  Phosbind Biotin LC provides a sequence-independent alternative for detecting protein phosphorylation in Western Blot workflows, addressing the limitations of phospho-specific antibodies. It is unsuitable for aqueous-only protocols or scenarios requiring long-term solution storage.

• CIAV VP2-CK2α Interaction: Mechanisms and Antiviral Implicat

  2026-04-30

  This study uncovers how chicken infectious anemia virus (CIAV) exploits host CK2α via direct interaction with VP2, facilitating efficient viral replication. The findings highlight the VP2-CK2α interface as a promising antiviral target and offer a mechanistic foundation for host-directed antiviral strategies against CIAV.

• Maximizing Assay Sensitivity with FITC Goat Anti-Mouse IgG (

  2026-04-29

  This article guides biomedical researchers through common challenges in cell-based immunoassays, emphasizing how SKU K1201, the FITC Goat Anti-Mouse IgG (H+L) Antibody, delivers reproducible, high-sensitivity results. Drawing on real-world scenarios and evidence-based insights, it demonstrates practical strategies for integrating this fluorescein-conjugated secondary antibody into reliable, workflow-friendly protocols.

• Optimizing Tumor and Neural Assays with Batimastat (BB-94)

  2026-04-29

  Batimastat (BB-94) empowers researchers to dissect matrix metalloproteinase (MMP) function in both cancer progression and neuromuscular synapse formation. This guide translates recent mechanistic breakthroughs into actionable protocols and troubleshooting strategies, maximizing the translational impact of Batimastat for in vitro and in vivo studies.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Cell Ent

  2026-04-28

  Chlorpromazine HCl, a benchmark dopamine receptor antagonist, offers a unique dual role in neuropharmacology and endocytic pathway research. Its validated, dose-tunable inhibition of clathrin-mediated endocytosis streamlines mechanistic studies and troubleshooting in infection and neuroscience workflows.

• ER Stress Impairs Intestinal Stem Cells via GRP78/ATF6/CHOP

  2026-04-28

  This study demonstrates that tunicamycin-induced endoplasmic reticulum (ER) stress diminishes intestinal stem cell (ISC) numbers and impairs their differentiation by activating the GRP78/ATF6/CHOP signaling pathway. The findings clarify the molecular links between ER stress and intestinal barrier dysfunction, with implications for understanding pathogenesis in gastrointestinal diseases.

15624 records 1/1042 page Next 12345 下5页 Last page